1. Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers 
B. Bozdogan, P.C. Appelbaum, L.M. Kelly, D.B. Hoellman, A. Tambic-Andrasevic, L. Drukalska, W. Hryniewicz, H. Hupkova, M.R. Jacobs, J. Kolman, M. Konkoly-Thege, J. Miciuleviciene, M. Pana, L. Setchanova, J. Trupl, P. Urbaskova 
Clinical Microbiology and Infection 
Volume 9, Issue 7, Pages (July 2003)
DOI: /j x
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
The geographic location of the 10 central and eastern European countries providing the S. pneumoniae strains.
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

3. Figure 2
Pulsed-field gel electrophoresis pattern of S. pneumoniae strains with ribosomal mutations after digestion with SmaI. Lane M, Staphylococcus aureus ATCC8325. S. pneumoniae strains: lane 1, HMC3474 with 23S rRNA mutation from Hungary; lane 2, HMC2686 with mutation in ribosomal protein L4 from Poland; lane 3, HMC2688 from Poland; lane 4, HMC3374 from Slovakia; lane 5, HMC3406 from Slovakia; lane 6, HMC3412 from Slovakia; lane 7, HMC3413 from Slovakia; lane 8, HMC3791 from the Czech Republic; lane 9, HMC5119 from Bulgaria; and lane 10, HMC3321 from Romania.
Clinical Microbiology and Infection 2003 9, DOI: ( /j x)
Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions